Combination therapy for overactive bladder study pulled before start
NCT ID NCT06438861
First seen Jan 10, 2026 · Last updated May 14, 2026 · Updated 24 times
Summary
This study aimed to see if adding the drug vibegron to Botox injections could better control overactive bladder in women who hadn't improved with other treatments. It planned to compare changes in urgent urine leaks between women getting vibegron plus Botox versus a placebo plus Botox. However, the study was withdrawn before any participants were enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERACTIVE BLADDER SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.